Found 6 results

↓ CSV
Name Type of Offering Accepted Date
Euclidean Fund For Cancer Research LP
D/A 2022-10-04 13:39:26
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001729236
Filed Document 0000919574-22-005772
Exclusions or Exemptions 506c
Accepted Date 2022-10-04 13:39:26
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclidean Fund For Cancer Research LP
D 2018-05-01 13:38:02
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001729236
Filed Document 0000919574-18-003237
Exclusions or Exemptions 506c
Accepted Date 2018-05-01 13:38:02
Type of Offering D
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclidean Fund For Cancer Research LP
D/A 2021-10-07 15:31:40
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001729236
Filed Document 0000919574-21-006153
Exclusions or Exemptions 506c
Accepted Date 2021-10-07 15:31:40
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclidean Fund For Cancer Research LP
D/A 2019-05-01 12:06:22
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001729236
Filed Document 0000919574-19-003082
Exclusions or Exemptions 506c
Accepted Date 2019-05-01 12:06:22
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclidean Fund For Cancer Research LP
D/A 2019-10-07 15:22:59
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001729236
Filed Document 0000919574-19-006264
Exclusions or Exemptions 506c
Accepted Date 2019-10-07 15:22:59
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclidean Fund For Cancer Research LP
D/A 2020-10-07 12:03:06
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001729236
Filed Document 0000919574-20-006214
Exclusions or Exemptions 506c
Accepted Date 2020-10-07 12:03:06
Type of Offering D/A
Industry Pooled Investment Fund
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity